3,621 Shares in Centene Co. (NYSE:CNC) Bought by Diversify Advisory Services LLC

Diversify Advisory Services LLC bought a new position in shares of Centene Co. (NYSE:CNC) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 3,621 shares of the company’s stock, valued at approximately $224,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Vantage Investment Partners LLC raised its position in Centene by 17.1% in the 3rd quarter. Vantage Investment Partners LLC now owns 683,817 shares of the company’s stock valued at $51,478,000 after buying an additional 99,904 shares during the last quarter. Polianta Ltd grew its stake in shares of Centene by 41.7% during the 4th quarter. Polianta Ltd now owns 22,100 shares of the company’s stock worth $1,338,000 after acquiring an additional 6,500 shares in the last quarter. State Street Corp raised its holdings in shares of Centene by 0.5% in the third quarter. State Street Corp now owns 23,468,159 shares of the company’s stock valued at $1,766,683,000 after purchasing an additional 111,654 shares during the last quarter. Daiwa Securities Group Inc. boosted its holdings in Centene by 31.1% during the third quarter. Daiwa Securities Group Inc. now owns 118,810 shares of the company’s stock worth $8,944,000 after purchasing an additional 28,175 shares during the last quarter. Finally, National Pension Service increased its stake in Centene by 15.4% in the 3rd quarter. National Pension Service now owns 1,435,482 shares of the company’s stock valued at $108,063,000 after buying an additional 191,768 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Up 2.5 %

CNC stock opened at $65.15 on Friday. The business’s fifty day moving average price is $60.36 and its two-hundred day moving average price is $67.26. The stock has a market capitalization of $32.89 billion, a price-to-earnings ratio of 11.31, a PEG ratio of 0.85 and a beta of 0.45. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $81.42. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10.

Insider Buying and Selling

In other news, CEO Sarah London acquired 4,117 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average price of $60.80 per share, with a total value of $250,313.60. Following the completion of the transaction, the chief executive officer now directly owns 667,229 shares of the company’s stock, valued at $40,567,523.20. This trade represents a 0.62 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas Greco bought 17,000 shares of the company’s stock in a transaction dated Wednesday, December 18th. The stock was purchased at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the transaction, the director now directly owns 19,309 shares in the company, valued at approximately $1,153,712.75. This represents a 736.25 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 45,010 shares of company stock valued at $2,660,276. 0.33% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently weighed in on CNC shares. Cantor Fitzgerald restated an “overweight” rating and issued a $90.00 price objective on shares of Centene in a report on Wednesday, December 11th. Truist Financial cut their price objective on Centene from $89.00 to $84.00 and set a “buy” rating for the company in a report on Friday, December 13th. Jefferies Financial Group downgraded shares of Centene from a “hold” rating to an “underperform” rating and lowered their target price for the stock from $68.00 to $52.00 in a report on Tuesday, December 10th. UBS Group upgraded shares of Centene from a “neutral” rating to a “buy” rating and increased their price target for the company from $79.00 to $80.00 in a research note on Friday, December 13th. Finally, Barclays upped their target price on shares of Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a report on Friday, December 13th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $80.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.